ECIL-8指南:儿童肿瘤及造血干细胞移植后抗生素使用建议
第八届欧洲白血病感染会议(ECIL-8)儿科组系统回顾文献,按ESCMID分级系统制定儿童肿瘤及造血干细胞移植患者抗生素使用推荐,涵盖预防性用药、初始治疗及降阶梯或停药策略,以死亡率、血流感染、发热性中性粒细胞减少、耐药出现及不良反应为评价终点。
要点
- 预防性抗菌用药评价终点包括死亡率、血流感染、发热性中性粒细胞减少、耐药及不良反应。
- 初始治疗与降阶梯或停药策略需区分临床稳定且无耐药菌感染或定植者与不稳定或有耐药菌感染或定植者。
- 推荐按ESCMID分级系统制定,涵盖预防、初始治疗及降阶梯策略。
核心结论
- ECIL-8儿科组总结了儿童肿瘤及造血干细胞移植患者抗菌预防、初始治疗及降阶梯策略的最终考虑与推荐。
研究设计与样本
- ECIL-8儿科组回顾文献,按欧洲临床微生物与感染性疾病学会(ESCMID)分级系统制定推荐。
主要发现
- 抗菌预防评价以死亡率、血流感染、发热性中性粒细胞减少、耐药出现及不良反应为终点。
- 初始抗菌治疗及降阶梯或停药聚焦于临床稳定且无既往耐药菌感染或定植者,以及临床不稳定或有既往耐药菌感染或定植者。
关键数值与推荐
- 推荐按ESCMID分级系统制定,涉及抗菌预防、初始治疗及降阶梯策略。
临床怎么用
- 临床可依据ECIL-8儿科组推荐,结合患者临床稳定性及耐药菌感染或定植史,决定抗菌预防、初始治疗及降阶梯或停药。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Paediatric patients with cancer and those undergoing haematopoietic cell transplantation are at high risk of bacterial infections. The 8th European Conference on Infections in Leukaemia (ECIL-8) convened a Paediatric Group to review the literature and to formulate recommendations for the use of antibiotics according to the European Society of Clinical Microbiology and Infectious Diseases grading system. The evaluation of antibacterial prophylaxis included mortality, bloodstream infection, febrile neutropenia, emergence of resistance, and adverse effects as endpoints. Initial antibacterial therapy and antibiotic de-escalation or discontinuation focused on patients with a clinically stable condition and without previous infection or colonisation by resistant bacteria, and on patients with a clinically unstable condition or with previous infection or colonisation by resistant bacteria. The final considerations and recommendations of the ECIL-8 Paediatric Group on antibacterial prophylaxis, initial therapy, and de-escalation strategies are summarised in this Policy Review.
引用
- Lehrnbecher T, Averbuch D, Castagnola E, et al. 8th European Conference on Infections in Leukaemia: 2020 guidelines for the use of antibiotics in paediatric patients with cancer or post-haematopoietic cell transplantation. Lancet Oncol. 2021. PMID: 33811814. doi:10.1016/S1470-2045(20)30725-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。